63083-6033 NDC - TRAVEL IMMUNIZATION DETOX

Drug Information

Product NDC: 63083-6033

Proprietary Name: Travel Immunization Detox

Non Proprietary Name: Travel Immunization Detox

Active Ingredient(s):
  • 12 [hp_X]/59mL ANOPHELES QUADRIMACULATUS;
  • 6 [hp_X]/59mL ARSENIC TRIOXIDE;
  • 12 [hp_X]/59mL CHOLERA ENTEROTOXIN SUBUNIT B;
  • 12 [hp_X]/59mL CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED);
  • 3 [hp_X]/59mL ECHINACEA ANGUSTIFOLIA WHOLE;
  • 12 [hp_X]/59mL HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED);
  • 12 [hp_X]/59mL JAPANESE ENCEPHALITIS VIRUS STRAIN NAKAYAMA-NIH ANTIGEN (FORMALDEHYDE INACTIVATED);
  • 30 [hp_X]/59mL MELANDRIN;
  • 12 [hp_X]/59mL MUMPS VIRUS;
  • 3 [hp_X]/59mL OYSTER SHELL CALCIUM CARBONATE, CRUDE;
  • 12 [hp_X]/59mL POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED);
  • 12 [hp_X]/59mL SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI;
  • 3 [hp_X]/59mL SILICON DIOXIDE;
  • 6 [hp_X]/59mL SULFUR;
  • 3 [hp_X]/59mL THUJA OCCIDENTALIS LEAF;
  • 12 [hp_X]/59mL YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Actively Acquired Immunity [PE];
  • Actively Acquired Immunity [PE];
  • Actively Acquired Immunity [PE];
  • Actively Acquired Immunity [PE];
  • Actively Acquired Immunity [PE];
  • Allergens [CS];
  • Cell-mediated Immunity [PE];
  • Hepatitis A Vaccines [CS];
  • Inactivated Clostridium Tetani Vaccine [EPC];
  • Inactivated Hepatitis A Virus Vaccine [EPC];
  • Inactivated Japanese Encephalitis Virus Vaccine [EPC];
  • Inactivated Poliovirus Vaccine [EPC];
  • Increased Histamine Release [PE];
  • Increased IgG Production [PE];
  • Insect Proteins [CS];
  • Japanese Encephalitis Vaccines [CS];
  • Live Attenuated Yellow Fever Virus Vaccine [EPC];
  • Non-Standardized Insect Allergenic Extract [EPC];
  • Poliovirus Vaccines [CS];
  • Tetanus Toxoid [CS];
  • Vaccines;
  • Attenuated [CS];
  • Vaccines;
  • Inactivated [CS];
  • Vaccines;
  • Inactivated [CS];
  • Vaccines;
  • Inactivated [CS];
  • Vaccines;
  • Inactivated [CS];
  • Yellow Fever Vaccine [CS]

Labeler Information

Labeler Name: Professional Complementary Health Formulas
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:8/15/1984

Package Information

No. Package Code Package Description Billing Unit
163083-6033-259 mL in 1 BOTTLE, DROPPER (63083-6033-2)

NDC Record

Field Name Field Value Definition
PRODUCT NDC63083-6033The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMETravel Immunization DetoxThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIX6033A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
NON PROPRIETARY NAMETravel Immunization DetoxThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE8/15/1984This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEProfessional Complementary Health FormulasName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEANOPHELES QUADRIMACULATUS; ARSENIC TRIOXIDE; CHOLERA ENTEROTOXIN SUBUNIT B; CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); ECHINACEA ANGUSTIFOLIA WHOLE; HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED); JAPANESE ENCEPHALITIS VIRUS STRAIN NAKAYAMA-NIH ANTIGEN (FORMALDEHYDE INACTIVATED); MELANDRIN; MUMPS VIRUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI; SILICON DIOXIDE; SULFUR; THUJA OCCIDENTALIS LEAF; YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGENAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH12; 6; 12; 12; 3; 12; 12; 30; 12; 3; 12; 12; 3; 6; 3; 12 
ACTIVE INGRED UNIT[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL 
PHARM CLASSESActively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Allergens [CS], Cell-mediated Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Hepatitis A Virus Vaccine [EPC], Inactivated Japanese Encephalitis Virus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Japanese Encephalitis Vaccines [CS], Live Attenuated Yellow Fever Virus Vaccine [EPC], Non-Standardized Insect Allergenic Extract [EPC], Poliovirus Vaccines [CS], Tetanus Toxoid [CS], Vaccines, Attenuated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Yellow Fever Vaccine [CS] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023